Stem Cells, Genome Editing, and the Path to Translational Medicine

Frank Soldner, Rudolf Jaenisch

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The derivation of human embryonic stem cells (hESCs) and the stunning discovery that somatic cells can be reprogrammed into human induced pluripotent stem cells (hiPSCs) holds the promise to revolutionize biomedical research and regenerative medicine. In this Review, we focus on disorders of the central nervous system and explore how advances in human pluripotent stem cells (hPSCs) coincide with evolutions in genome engineering and genomic technologies to provide realistic opportunities to tackle some of the most devastating complex disorders. Advances in stem cell biology are paving new paths toward their use in the clinic, especially toward understanding and treating neurological and neurodegenerative disease.

Original languageEnglish (US)
Pages (from-to)615-632
Number of pages18
JournalCell
Volume175
Issue number3
DOIs
StatePublished - Oct 18 2018
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Pluripotent Stem Cells
Regenerative Medicine
Translational Medical Research
Central Nervous System Diseases
Stem cells
Neurodegenerative Diseases
Medicine
Cell Biology
Biomedical Research
Stem Cells
Genes
Genome
Technology
Cytology
Neurodegenerative diseases
Neurology
Gene Editing
Human Embryonic Stem Cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Stem Cells, Genome Editing, and the Path to Translational Medicine. / Soldner, Frank; Jaenisch, Rudolf.

In: Cell, Vol. 175, No. 3, 18.10.2018, p. 615-632.

Research output: Contribution to journalReview article

Soldner, Frank ; Jaenisch, Rudolf. / Stem Cells, Genome Editing, and the Path to Translational Medicine. In: Cell. 2018 ; Vol. 175, No. 3. pp. 615-632.
@article{260015f4a6914d6c9dcedf44ee55da3c,
title = "Stem Cells, Genome Editing, and the Path to Translational Medicine",
abstract = "The derivation of human embryonic stem cells (hESCs) and the stunning discovery that somatic cells can be reprogrammed into human induced pluripotent stem cells (hiPSCs) holds the promise to revolutionize biomedical research and regenerative medicine. In this Review, we focus on disorders of the central nervous system and explore how advances in human pluripotent stem cells (hPSCs) coincide with evolutions in genome engineering and genomic technologies to provide realistic opportunities to tackle some of the most devastating complex disorders. Advances in stem cell biology are paving new paths toward their use in the clinic, especially toward understanding and treating neurological and neurodegenerative disease.",
author = "Frank Soldner and Rudolf Jaenisch",
year = "2018",
month = "10",
day = "18",
doi = "10.1016/j.cell.2018.09.010",
language = "English (US)",
volume = "175",
pages = "615--632",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Stem Cells, Genome Editing, and the Path to Translational Medicine

AU - Soldner, Frank

AU - Jaenisch, Rudolf

PY - 2018/10/18

Y1 - 2018/10/18

N2 - The derivation of human embryonic stem cells (hESCs) and the stunning discovery that somatic cells can be reprogrammed into human induced pluripotent stem cells (hiPSCs) holds the promise to revolutionize biomedical research and regenerative medicine. In this Review, we focus on disorders of the central nervous system and explore how advances in human pluripotent stem cells (hPSCs) coincide with evolutions in genome engineering and genomic technologies to provide realistic opportunities to tackle some of the most devastating complex disorders. Advances in stem cell biology are paving new paths toward their use in the clinic, especially toward understanding and treating neurological and neurodegenerative disease.

AB - The derivation of human embryonic stem cells (hESCs) and the stunning discovery that somatic cells can be reprogrammed into human induced pluripotent stem cells (hiPSCs) holds the promise to revolutionize biomedical research and regenerative medicine. In this Review, we focus on disorders of the central nervous system and explore how advances in human pluripotent stem cells (hPSCs) coincide with evolutions in genome engineering and genomic technologies to provide realistic opportunities to tackle some of the most devastating complex disorders. Advances in stem cell biology are paving new paths toward their use in the clinic, especially toward understanding and treating neurological and neurodegenerative disease.

UR - http://www.scopus.com/inward/record.url?scp=85054577925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054577925&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2018.09.010

DO - 10.1016/j.cell.2018.09.010

M3 - Review article

C2 - 30340033

AN - SCOPUS:85054577925

VL - 175

SP - 615

EP - 632

JO - Cell

JF - Cell

SN - 0092-8674

IS - 3

ER -